Pyrosequencing™-based screening for the genetic polymorphism CYP2B6 1459 C>T

被引：0
|
作者：
Doehring, Alexandra [1 ]
Loetsch, Joern [1 ]
机构：
[1] Goethe Univ Frankfurt, Pharmazentrum Frankfurt ZAFES, Inst Clin Pharmacol, D-60590 Frankfurt, Germany
来源：
PHARMACOGENOMICS | 2009年 / 10卷 / 10期
关键词：
CYTOCHROME P4502B6; THERAPY;
D O I：
10.2217/PGS.09.123
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：1577 / 1579
页数：3
相关论文
共 50 条
  • [31] Genetic variability of CYP2D6, CYP2B6, CYP2C9 and CYP2C19 genes across the Italian Peninsula
    Carano, Francesco
    Sarno, Stefania
    De Fanti, Sara
    Serventi, Patrizia
    Bini, Carla
    Luiselli, Donata
    Pelotti, Susi
    ANNALS OF HUMAN BIOLOGY, 2018, 45 (01) : 66 - 71
  • [32] The Effect Of The Cyp1a2-163 c>A Polymorphism On The Metabolism Of Caffeine And Effect On Performance
    Giersch, Gabrielle E. W.
    Boyett, James C.
    Luden, Nicholas D.
    Hughey, Christine A.
    Saunders, Michael J.
    Hargens, Trent A.
    Daley, Hannah
    El-Sohemy, Ahmed
    Womack, Christopher J.
    MEDICINE AND SCIENCE IN SPORTS AND EXERCISE, 2017, 49 (05): : 293 - 293
  • [33] Distribution of CYP2B6 516G/T pharmacogenetically important polymorphism in the Ukrainian population
    Filiptsova, Olga
    Kobets, Marina
    Kobets, Julia
    Naboka, Olga
    Koiro, Olga
    Ochkur, Alexandr
    Galiy, Larisa
    SAUDI PHARMACEUTICAL JOURNAL, 2018, 26 (05) : 651 - 655
  • [34] Impact of CYP2B6 983T>C polymorphism on non-nucleoside reverse transcriptase inhibitor plasma concentrations in HIV-infected patients
    Wyen, Christoph
    Hendra, Heidy
    Vogel, Martin
    Hoffmann, Christian
    Knechten, Heribert
    Brockmeyer, Norbert H.
    Bogner, Johannes R.
    Rockstroh, Juergen
    Esser, Stefan
    Jaeger, Hans
    Harrer, Thomas
    Mauss, Stefan
    van Lunzen, Jan
    Skoetz, Nicole
    Jetter, Alexander
    Groneuer, Christiane
    Faetkenheuer, Gerd
    Khoo, Saye H.
    Egan, Deirdre
    Back, David J.
    Owen, Andrew
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2008, 61 (04) : 914 - 918
  • [35] Plasma levels of efavirenz and frequency of the CYP2B6 516G>T polymorphism in people living with HIV-1 in Mexico
    Ortiz-Rodriguez, M. A.
    Oaxaca-Navarro, J.
    Patino-Camacho, S., I
    Garcia-Jimenez, S.
    Deciga-Campos, M.
    Martinez-Salazar, M. F.
    PHARMAZIE, 2022, 77 (06): : 191 - 195
  • [36] Prevalence of CYP2B6 polymorphisms in Argentinians: the role of genetic testing
    Scibona, P.
    Vazquez, C.
    Cajal, A. R.
    Argibay, P. F.
    Belloso, W. H.
    GENETICS AND MOLECULAR RESEARCH, 2015, 14 (04): : 16594 - 16599
  • [37] Effect of CYP2B6*6 and CYP2C19*2 genotype on chlorpyrifos metabolism
    Crane, Alice L.
    Klein, Kathrin
    Zanger, Ulrich M.
    Olson, James R.
    TOXICOLOGY, 2012, 293 (1-3) : 115 - 122
  • [38] Effects of CYP3A5, CYP2C19, and CYP2B6 on the clinical efficacy and adverse outcomes of sibutramine therapy: A crucial role for the CYP2B6*6 allele
    Hwang, In Cheol
    Park, Ji Young
    Ahn, Hong Yup
    Kim, Kyoung Kon
    Suh, Heuy Sun
    Ko, Ki Dong
    Kim, Kyoung-Ah
    CLINICA CHIMICA ACTA, 2014, 428 : 77 - 81
  • [39] Stereoselective metabolism of methadone (M) by CYP2B6 and CYP2C19.
    Gerber, JG
    Rhodes, RJ
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2001, 69 (02) : P11 - P11
  • [40] Direct sequencing and comprehensive screening of genetic polymorphisms on CYP2 family genes (CYP2A6, CYP2B6, CYP2C8, and CYP2E1) in five ethnic populations
    Jeong-Hyun Kim
    Hyun Sub Cheong
    Byung Lae Park
    Lyoung Hyo Kim
    Hee Jung Shin
    Han Sung Na
    Myeon Woo Chung
    Hyoung Doo Shin
    Archives of Pharmacal Research, 2015, 38 : 115 - 128
12345